基于药品采购数据库的上海市各级医疗机构降糖药物利用情况分析

发布时间：2018-04-26 09:22

本文选题：药品采购 + 糖尿病　；参考：《中国卫生经济》2017年03期

【摘要】：目的:分析上海市降糖药物利用情况,并对各级医疗机构用药合理性进行评价。方法:对上海市医疗机构药品招标数据库中2013年11月—2014年10月一年期降糖药的采购金额、单价和剂量等进行统计,采用世界卫生组织(WHO)推荐的用药频度(DDDs)和日均费用(DDDc)方法。结果:分析药物构成发现,上海市各级医疗机构降糖药用药频率最高的为磺脲类药物(53.84%),其次为胰岛素和二甲双胍类降糖药。分析采购金额发现,一级、二级和三级医疗机构的降糖药采购金额分别为5.73亿元、3.22亿元和3.39亿元。将DDDs值按通用名排序后发现,上海市降糖药用药频率最高的药品为格列齐特、格列美脲和重组人胰岛素等。各级医疗机构降糖药采购的平均一致性为68.69%。结论:上海市糖尿病患者主要在社区配药,日治疗费用较为合理。糖尿病用药构成基本合理,降糖药以磺脲类、胰岛素和二甲双胍类为主,磺脲类占主导地位。一、二级医疗机构用药更为接近。
[Abstract]:Objective: to analyze the utilization of hypoglycemic drugs in Shanghai and evaluate the rationality of drug use in medical institutions at all levels. Methods: the purchase amount, unit price and dose of single-year hypoglycemic drugs from November 2013 to October 2014 in Shanghai Medical institutions' Drug bidding Database were analyzed, and the DDDs and DDDc methods recommended by WHO (World Health Organization) were used. Results: it was found that the highest frequency of hypoglycemic drugs in Shanghai was sulfonylurea, followed by insulin and metformin. The purchase amount of hypoglycemic drugs was 573 million yuan, 322 million yuan and 339 million yuan for the first, second and third level medical institutions, respectively. The results showed that the most frequently used antidiabetic drugs in Shanghai were gliclazide, glimepiride and recombinant human insulin. The average consistency of the purchase of hypoglycemic drugs in medical institutions at all levels was 68.69. Conclusion: diabetic patients in Shanghai are mainly dispensed in community, and the daily treatment cost is reasonable. The drug composition of diabetes mellitus was basically reasonable. The main hypoglycemic drugs were sulfonylurea, insulin and metformin, and sulfonylurea was dominant. First, the level II medical institutions are more close to the use of drugs.
【作者单位】：上海市卫生发展研究中心;上海市卫生和计划生育委员会;上海市医药集中招标采购事务所;复旦大学公共卫生学院;
【基金】：美国中华医学基金会卫生体系研究与政策转化合作项目(CMB-CP 14-190) 上海市卫生和计划生育委员会定向委托课题(2015HP009)
【分类号】：R977.15

【参考文献】